$THRM

Gentherm (THRM) Stock Faces 1.7% Net Margin Strain Challenging Bullish Growth Narrative

Simply Wall St reports Gentherm (THRM) Q2 2026 revenue of $416.2m and basic EPS of $0.14. Trailing 12-month revenue is $1.58b with basic EPS $0.87 and a net margin of 1.7%, down from 2.2% a year earlier, after a $25.1m one-off loss. Shares trade at a trailing P/E of 49.3x versus peers 16.4x-20.6x.

Original reporting
Published Jul 24, 2026, 11:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 4:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gentherm (THRM) Stock Faces 1.7% Net Margin Strain Challenging Bullish Growth Narrative — source image
Decision brief

The 30-second read

$THRMBearishLow
01

Why it matters

The key trading takeaway is the mismatch between top-line growth and weak trailing net margin, which can justify multiple compression when expectations are already high.

02

Market read

For THRM, the article highlights margin pressure (1.7% net margin) and a high trailing P/E (49.3x), challenging the bullish growth narrative.

03

What to watch

The article references a prior one-off loss but does not quantify current cost structure changes or segment profitability, so the sustainability of the 1.7% margin is not fully evidenced here.

Relevance 4/10Novelty 4/10Timing: post-Q2 2026 scorecard framing for margin and valuation

Background

The article summarizes Gentherm’s Q2 2026 results and compares trailing profitability and valuation to prior-year levels and peers.

Company-level read

Ticker impact

$THRMBearishMedium confidence
Context

Gentherm reports Q2 2026 revenue of $416.2M and trailing net margin of 1.7%, down from 2.2% a year earlier.

Expected impact

Near-term downside bias versus valuation if investors treat the 1.7% net margin as persistent rather than temporary.

Evidence & confidence

The article’s newest concrete datapoints are the Q2 2026 scorecard and the trailing 12-month net margin (1.7% vs 2.2% prior year), alongside valuation metrics (49.3x trailing P/E). That combination typically pressures multiples when margins are not improving.

Market effects

Auto components investors may re-focus on profitability durability, not just revenue growth, for thermal management and comfort systems suppliers.

No specific regional catalyst beyond US-listed company fundamentals.

Limited, as the piece is company-specific and does not cite global regulatory or demand shocks.

Counterpoint

Revenue growth (12.6% YoY) and a higher DCF fair value versus the current price suggest the market may be underpricing a future margin recovery.

Key entities

  • Gentherm

    US-listed auto components supplier reporting Q2 2026 scorecard and trailing net margin of 1.7%.

  • Simply Wall St

    Publishes fundamental commentary using historical data and analyst forecasts.

Related articles

$THRMMed

Gentherm Incorporated Q2 2026 Earnings Call Summary

Gentherm reported Q2 2026 results and an earnings-call outlook. It cited 12.7% organic automotive growth versus a 3% global light-vehicle production decline, FDA 510(k) clearance for ThermAffyx, and an IME acquisition to access VA hospitals. Gentherm expects the Modine Performance Technologies merger to close in early Q4 2026, targeting $3.5B revenue by 2030, $400M buyback, and $800M committed financing.

$THRMHighAI 9/10

Gentherm (THRM) Q2 2026 Earnings Call Transcript

Gentherm (THRM) reported Q2 2026 product revenue of $416 million, up 11% year over year, with 9.5% organic growth. Automotive climate and comfort revenue rose 14.1% (12.7% ex FX). Adjusted EBITDA was $48.8 million and non-GAAP EPS $0.75. The company raised 2026 guidance to $1.6 billion revenue and $185-$200 million adjusted EBITDA, and authorized $400 million in buybacks.

$THRMMedAI 8/10

Gentherm Q2 Earnings Call Highlights

Gentherm (NASDAQ:THRM) reported adjusted EBITDA of $48.8M (11.7% of sales) and adjusted EPS of $0.75 for Q2. Management cited margin pressure from timing, inventory reductions and warranty accruals. Gentherm raised 2026 guidance to $1.6B revenue and $185M-$200M adjusted EBITDA, and expects ThermAffyx initial sales in Q3.